FibroGen Appoints Maykin Ho, Ph.D., to Board of Directors

World News: . []

SAN FRANCISCO Dec 06 2018 GLOBE NEWSWIRE -- FibroGen, Inc NASDAQ FGEN a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics today announced the appointment of Maykin Ho PhD as an in depende...

More news and information about FibroGen, Inc

Published By:

Globe Newswire: 09:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "fibrogen" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us